Exploring the views of infection consultants in England on a novel delinked funding model for antimicrobials: the SMASH study.

Ioannis BaltasMark GilchristEirini KoutoumanouMalick M GibaniJames E MeiringAkaninyene OtuDavid HettleAmeeka ThompsonJames R PriceAnna CrepetAbolaji AtomodeTimothy Crocker-BuqueDimitrios SpinosHudson GuyverMatija TausanDonald SomasunderamMaxwell ThoburnCathleen ChanHelen UmplebyBethany SharpCallum ChiversDevan Suresh VaghelaRonak J ShahJonathan FosterAmy HumeChristopher SmithAmmara AsifDimitrios MermerelisMohammad Abbas RezaDominic A HaighThomas LambLoucia KaratziaAlexandra BramleyNikhil KadamKonstantinos KavallierosVeronica Garcia-AriasJane DemocratisClaire S WaddingtonLuke Stephen Prockter Moore Alexander M Aiken

Published in: JAC-antimicrobial resistance (2023)

The 'subscription-type' model was viewed favourably by infection consultants in England.

Keyphrases